1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with betamethasone sodium phosphate in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (betamethasone sodium phosphate) | Trials (betamethasone sodium phosphate) | Recent Studies (post-2010) (betamethasone sodium phosphate) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 184 | 33 | 47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirasawa, E; Tsuji, F | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and betamethasone sodium phosphate
| Article | Year |
|---|---|
The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs.
Topics: Animals; Anterior Chamber; Aqueous Humor; Azepines; Betamethasone; Chemotaxis, Leukocyte; Dinoprostone; Escherichia coli; Flow Cytometry; Guinea Pigs; Indomethacin; Leukocyte Count; Leukocytes; Lipopolysaccharides; Male; Ophthalmic Solutions; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Uveitis, Anterior | 1998 |